The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 25.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 48% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 166%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it strong buy, with a mean price target of $356.
Onto Innovation Inc ONTO
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Onto Innovation Inc.
read at $331.71
Onto Innovation Inc holds its Markup at $331.71.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 248 days |
| Price | $331.71 |
| Valuation | 124.24 trailing · 28.67 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.59 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 35.30% |
| Profit margin | 11.84% |
| Debt to equity | 76.55 |
| Analyst consensus | Strong Buy · 10 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 0.7% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 12.4% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 26.0% of assets, under the 49% limit. Pass
- Revenue purity Only 3.5% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Chip inspection tools sit in a value trap
Picture a factory line that only runs flat out when chipmakers splash cash on new capacity. Onto sells the inspection tools that keep those lines honest, yet the business earns a thin 10 percent margin and just 5 percent ROE in an industry that stops dead every few years.
We pass because the shares trade well above our fair value with a forward multiple of 28 times on single-digit revenue growth and a narrow moat. In cyclical equipment names that pattern usually signals peak earnings rather than a bargain, leaving investors exposed when orders fade.
The ethical screen clears, yet the combination of high valuation, low returns and cycle risk gives no margin of safety. Analysis, not advice.
| Forward P/E | 28.7x fairly priced for its growth rate |
| Trailing P/E | 124.2x expensive — the price assumes strong growth ahead |
| Revenue growth | 35.3% strong top-line growth |
| Profit margin | 11.8% thin but positive margins |
| Return on equity | 6.8% a modest return on shareholder capital |
| Debt to equity | 0.77 moderate, manageable leverage |
| Current ratio | 9.73 comfortably covers its short-term bills |
| Beta | 1.59 much more volatile than the market |
| Market cap | $20.3B |
| Employees | 1,615 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in ONTO's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 48% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 166%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it strong buy, with a mean price target of $356.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $287.52 | -6.1% | · | $939 | -6.1% |
| 2 months | $257.14 | +5.0% | · | $1,050 | +5.0% |
| 3 months | $184.59 | +46.3% | · | $1,463 | +46.3% |
| 6 months | $160.37 | +68.3% | · | $1,683 | +68.3% |
| 1 year | $101.34 | +166.4% | · | $2,664 | +166.4% |
| 2 years | $218.28 | +23.7% | · | $1,237 | +23.7% |
| 3 years | $110.10 | +145.2% | · | $2,452 | +145.2% |
| 5 years | $74.98 | +260.1% | · | $3,601 | +260.1% |
Historical returns from market close data. Past performance does not guarantee future results.